Top Medical Stocks To Consider – February 02nd

UnitedHealth Group, AbbVie, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer to equities in companies that are involved in the manufacturing, distribution, sale, or development of medical products, devices, equipment, or pharmaceuticals. Investors often include medical stocks in their portfolios to capitalize on the growth potential of the healthcare industry and the increasing demand for healthcare products and services. These stocks can be sensitive to regulatory changes, clinical trial outcomes, and broader economic conditions. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH stock traded down $3.27 during trading on Friday, hitting $542.30. 4,120,450 shares of the stock traded hands, compared to its average volume of 4,209,506. UnitedHealth Group has a one year low of $436.38 and a one year high of $630.73. The company has a 50 day simple moving average of $536.17 and a 200 day simple moving average of $565.26. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $499.07 billion, a price-to-earnings ratio of 34.99, a P/E/G ratio of 1.46 and a beta of 0.62.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

ABBV traded up $8.25 during trading on Friday, hitting $183.90. The company’s stock had a trading volume of 11,926,469 shares, compared to its average volume of 5,362,292. AbbVie has a 12 month low of $153.58 and a 12 month high of $207.32. The stock has a market capitalization of $324.98 billion, a price-to-earnings ratio of 63.85, a price-to-earnings-growth ratio of 1.77 and a beta of 0.58. The company has a quick ratio of 0.54, a current ratio of 0.65 and a debt-to-equity ratio of 9.64. The firm’s 50 day moving average price is $176.57 and its two-hundred day moving average price is $185.06.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded down $11.62 during mid-day trading on Friday, reaching $811.61. 2,560,693 shares of the company were exchanged, compared to its average volume of 3,594,702. The company has a quick ratio of 0.97, a current ratio of 1.27 and a debt-to-equity ratio of 2.03. The stock has a market cap of $770.48 billion, a PE ratio of 87.74, a PEG ratio of 1.71 and a beta of 0.41. Eli Lilly and Company has a 12 month low of $637.00 and a 12 month high of $972.53. The company has a fifty day moving average of $783.56 and a 200 day moving average of $844.18.